UTC Pluristem Exclusive License Agreement between Pluristem Ltd. and United Therapeutics Corporation Dated: June 19, 2011Utc Pluristem Exclusive License Agreement • September 12th, 2011 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances) • New York
This Exclusive License Agreement (the “Agreement”) is made and entered into as of June 19, 2011 (the “Execution Date”) by and between Pluristem Ltd. an Israel corporation, having its principal place of business at MATAM Advanced Technology Park, Building No. 20, Haifa 31905 Israel (“Pluristem”), and United Therapeutics Corporation, a Delaware corporation, having its principal place of business at 1040 Spring Street, Silver Spring, MD, 20910, USA (“UTC”). Pluristem and UTC are referred to individually as a “Party” and collectively as the “Parties.”
ContractLease Agreement • September 12th, 2011 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances)
